Examining Differences in Opportunity and Eligibility for Cancer Clinical Trial Participation Based on Sociodemographic and Disease Characteristics
Jessica Rearden, PhD, RN; Alexandra L. Hanlon, PhD; Connie Ulrich, PhD, RN, FAAN; Margo Brooks-Carthon, PhD, CRNP; and Marilyn Sommers, PhD, RN, FAAN
ONF
10.1188/16.ONF.57-66
Description
Design: A matched cross-sectional study including a prospective oral questionnaire and retrospective electronic medical record (EMR) review.
Setting: A single hospital in a large academic National Cancer Institute–designated cancer center in Philadelphia, Pennsylvania.
Sample: 44 Black or Hispanic and 44 Non-Hispanic White newly diagnosed individuals matched on cancer type and age (plus or minus five years).
Methods: Participants answered a questionnaire to capture self-reported opportunity for CCT participation, sociodemographic information, and cancer type. With consent, the authors completed a retrospective review of the EMR to assess eligibility and collect cancer stage and performance status.